
Sepsis, a leading cause of hospital deaths, sees potential in thiamine (vitamin B1) treatment. Recent modest-sized clinical trials indicate some benefits, although more research is needed. One study revealed thiamine-administered patients had more ICU-free days, while another found no significant difference in mortality rates. However, thiamine deficiency measurement methods and target populations require further exploration. Sepsis treatment with thiamine remains in the research phase.
Like
Save
Share